Coping and Communication Skills Training for Gynecologic Cancers

SL
Overseen BySharon L Manne, PhD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Rutgers, The State University of New Jersey
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to evaluate the effectiveness of the Journey Ahead intervention in helping individuals with gynecologic cancers enhance their coping and communication skills. Participants will engage in eight sessions and six phone calls focused on these skills. The program is designed for those diagnosed with specific types of gynecologic cancers, such as ovarian or cervical cancer, who have undergone treatment or surgery in the past five years. Participants must have internet access and be able to communicate in English to take part in online and phone sessions. As an unphased trial, this study offers a unique opportunity to contribute to research that could improve support for others facing similar challenges.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What prior data suggests that the Journey Ahead intervention is safe for participants with gynecologic cancers?

Research has shown that the Journey Ahead program helps women with gynecologic cancers enhance their coping skills and communication. In a previous study, 14 women diagnosed and treated for these cancers participated in the Journey Ahead program. They completed eight online sessions, and no negative effects were reported, suggesting participants generally tolerate the program well.

As the program involves coaching sessions rather than medication or surgery, the risk of physical harm remains very low. It is designed to help participants manage stress and improve communication. Overall, evidence indicates that Journey Ahead is safe for participants.12345

Why are researchers excited about this trial?

Researchers are excited about the "Journey Ahead" program because it focuses on developing coping and communication skills specifically for individuals with gynecologic cancers. Unlike conventional treatments that might focus on medication or surgery, this intervention emphasizes psychological support through 8 sessions and 6 phone calls, potentially improving patients' mental well-being and quality of life. This approach is unique because it recognizes the importance of emotional and communicative strength in managing cancer, offering a holistic complement to standard medical treatments.

What evidence suggests that the Journey Ahead intervention is effective for improving coping and communication skills in gynecologic cancer patients?

Research shows that the Journey Ahead program, provided to participants in this trial, helps individuals with gynecologic cancers improve coping and communication skills. Studies have found that similar methods, such as cognitive-behavioral therapy, effectively reduce symptoms in women with these cancers. Early results suggest that Journey Ahead, which combines online and telehealth coaching, is practical and well-received by participants. While specific data on its effectiveness is still being gathered, the program relies on proven techniques to support emotional and social well-being.12367

Who Is on the Research Team?

SL

Sharon L Manne, PhD

Principal Investigator

Rutgers Cancer Institute of New Jersey

Are You a Good Fit for This Trial?

This trial is for women over 18 who've been diagnosed with various gynecological cancers, including uterine, ovarian, and cervical cancer. Participants should be within 5 years post-cancer surgery or treatment like chemo or radiation and must have internet access to view online sessions.

Inclusion Criteria

I was diagnosed with Stage 2 or higher cervical cancer or had a recurrence in the last 5 years.
I can access the internet and participate in online sessions and telehealth chats.
I am mostly active and can carry out my daily activities.
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants engage in the Journey Ahead intervention focusing on coping and communication skill development during the course of 8 sessions and 6 phone calls.

8 weeks

Follow-up

Participants are monitored for changes in distress, coping, and other psychological measures post-intervention.

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Journey Ahead
Trial Overview The 'Journey Ahead' intervention is being tested to see if it helps improve coping and communication skills in women with gynecologic cancers. It involves informational sessions viewed online followed by discussions via phone or video chat.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Journey AheadExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials
471
Recruited
81,700+

Published Research Related to This Trial

A study involving 16 women with gynecologic cancer identified that family support was the most significant coping strategy, with 96.8% of participants relying on it, and 71.4% found talking about their experiences helpful.
Despite the emotional support from healthcare providers, only a small percentage attended counseling or support groups, indicating a need for improved access to supportive resources and information about available workshops to enhance coping strategies during their cancer journey.
Coping with cancer: examining the supports available to women with gynecologic cancer at Saskatoon Cancer Center.Smith, SN., Chizen, D., Agrawal, A.[2018]
A study involving 646 women tested for hereditary breast or ovarian cancer revealed that coping strategies, particularly avoidance, were strongly linked to negative emotions and psychosocial difficulties, especially in those receiving a pathogenic variant result.
Network analysis showed that cognitive restructuring was associated with lower psychosocial difficulties, suggesting that targeted counseling could help improve coping strategies and emotional adjustment after genetic testing.
How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.Brédart, A., Dick, J., Cano, A., et al.[2020]
The coping and communication-enhancing intervention (CCI) significantly reduced depressive symptoms and cancer-specific distress in 352 women with gynecological cancer over the first six months compared to supportive counseling (SC) and usual care (UC).
Unlike SC, which showed no significant benefits, CCI improved emotional well-being and demonstrated that structured psychological interventions are essential for effectively addressing distress in newly diagnosed cancer patients.
A comparison of two psychological interventions for newly-diagnosed gynecological cancer patients.Manne, SL., Virtue, SM., Ozga, M., et al.[2018]

Citations

Journey Ahead: Enhancing Coping and Communication for ...This study looks at how well the Journey Ahead intervention works in improving coping and communication skills in participants with gynecologic cancers.
Coping and Communication Skills Training for Gynecologic ...This trial tests the Journey Ahead online program, which helps people with gynecologic cancers improve their coping and communication skills.
Journey Ahead: Enhancing Coping and Communication for ...This study looks at how well the Journey Ahead intervention works in improving coping and communication skills in participants with gynecologic
An online and telehealth intervention for women diagnosed...The aim of this study was to evaluate the feasibility, acceptability, and preliminary effects of Journey Ahead, a blended online and telehealth coaching ...
The effectiveness of cognitive behavioral therapy in women ...Cognitive behavioral therapy was shown to be a useful treatment for the symptoms experienced by women with gynecological cancer, with significant effect sizes.
Ovarian cancer - PMC - PubMed Central - NIHOvarian cancer is a global problem, is typically diagnosed at a late stage and has no effective screening strategy.
Machine Learning Models for Predicting Gynecological CancersThis review explores how machine learning, an advanced computer-based method, is changing the way healthcare professionals detect and treat ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security